Back to results
CompletedPhase 3

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

NCT00199394

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Kyowa Hakko UK Ltd.

Slough, Berkshire, United Kingdom

View on ClinicalTrials.gov
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease — TrialFind